Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Interest Expense : $-0.04 Mil (TTM As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cannabis Bioscience International Holdings's interest expense for the six months ended in Nov. 2023 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Nov. 2023 was $-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cannabis Bioscience International Holdings's Operating Income for the six months ended in Nov. 2023 was $ -0.27 Mil. Cannabis Bioscience International Holdings's Interest Expense for the six months ended in Nov. 2023 was $ -0.04 Mil. Cannabis Bioscience International Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannabis Bioscience International Holdings Interest Expense Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Interest Expense Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

Interest Expense

-0.16

-0.37

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Interest Expense	Get a 7-Day Free Trial							-0.10	-0.26	-0.01	-0.05	-0.04

Cannabis Bioscience International Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.04 Mil.

Cannabis Bioscience International Holdings (OTCPK:CBIH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannabis Bioscience International Holdings's Interest Expense for the six months ended in Nov. 2023 was $-0.04 Mil. Its Operating Income for the six months ended in Nov. 2023 was $-0.27 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Nov. 2023 was $0.28 Mil.

Cannabis Bioscience International Holdings's Interest Coverage for the quarter that ended in Nov. 2023 is calculated as

Cannabis Bioscience International Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.